# Plain Language Summary: American Medical Innovation and Investment Act of 2024

This bill makes several changes to Medicare to expand coverage for new medical technologies and improve how Medicare evaluates treatments. The main focus is on helping Medicare keep pace with medical innovation while ensuring patients can access newer treatments more easily.

The bill's first major change requires Medicare to include cognitive impairment screening as part of routine annual wellness visits and initial physical exams for seniors starting in 2025. Doctors will use standardized tests approved by the National Institute on Aging to check for early signs of memory problems or cognitive decline, and they'll document the results in patients' medical records. This is meant to catch cognitive issues earlier when interventions might be more effective.

The bill also streamlines how Medicare decides whether to cover new medical devices and treatments. Currently, Medicare can approve items "with evidence development," meaning they cover something temporarily while more research is being done, but there's no deadline for when Medicare must reconsider that decision. This bill requires Medicare to revisit these temporary approvals within ten years and make a final determination. Additionally, when companies submit requests for Medicare coverage decisions, Medicare must respond within 90 days explaining whether the request is complete or what additional information is needed. The bill also requires local Medicare contractors to ensure their coverage decisions don't contradict national policies.

The bill expands coverage for home infusion pumps and drugs that require professional supervision, making it easier for patients who need ongoing IV or subcutaneous medications to receive them at home rather than in medical facilities. It also directs Medicare to issue guidance by 2026 on how to handle payment for newer technologies like artificial intelligence-powered glucose monitors and prescription digital therapeutics—software-based treatments that patients use on their phones or computers under a doctor's prescription. These changes aim to remove barriers that might prevent seniors from accessing innovative treatments while maintaining appropriate oversight.